Tumor xenograft modeling identifies an association between TCF4 loss and breast cancer chemoresistance

Understanding the mechanisms of cancer therapeutic resistance is fundamental to improving cancer care. There is clear benefit from chemotherapy in different breast cancer settings; however, knowledge of the mutations and genes that mediate resistance is incomplete. In this study, by modeling chemore...

Descripció completa

Dades bibliogràfiques

Autors principals:	Gorka Ruiz de Garibay, Francesca Mateo, Agostina Stradella, Rafael Valdés-Mas, Luis Palomero, Jordi Serra-Musach, Diana A. Puente, Ander Díaz-Navarro, Gardenia Vargas-Parra, Eva Tornero, Idoia Morilla, Lourdes Farré, María Martinez-Iniesta, Carmen Herranz, Emmet McCormack, August Vidal, Anna Petit, Teresa Soler, Conxi Lázaro, Xose S. Puente, Alberto Villanueva, Miguel Angel Pujana
Format:	Artigo
Idioma:	Inglês
Publicat:	The Company of Biologists 2018-05-01
Col·lecció:	Disease Models & Mechanisms
Matèries:	Breast cancer Chemotherapy Resistance TCF4 Xenograft Transcription factor Patient-derived xenograft
Accés en línia:	http://dmm.biologists.org/content/11/5/dmm032292
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!